Jetrence L Oral Suspension is a hepatoprotective formulation containing Silymarin (35 mg/5 ml) and Lecithin (262.5 mg/5 ml), designed to support liver function and promote hepatic cell regeneration. Silymarin, a flavonoid complex extracted from the milk thistle plant, exhibits potent antioxidant, anti-inflammatory, and antifibrotic properties, which help in protecting hepatocytes from oxidative stress and toxin-induced damage. Lecithin, a phospholipid, plays a crucial role in maintaining cellular membrane integrity and facilitating lipid metabolism, thereby enhancing liver repair mechanisms. This combination is indicated for the management of various liver disorders, including chronic hepatitis, fatty liver disease, and toxin-induced hepatic injury. Jetrence L Oral Suspension aids in improving liver enzyme profiles and overall liver function, contributing to the restoration of normal hepatic architecture. It is typically administered orally, with dosage adjusted according to the severity of the condition and patient response. The suspension form ensures ease of administration and improved patient compliance, especially in pediatric and geriatric populations. Jetrence L is generally well tolerated, with minimal adverse effects reported. It is recommended to use this medication under medical supervision to optimize therapeutic outcomes and monitor liver function parameters regularly.